FIELD: medicine.
SUBSTANCE: method involves administration of hyaluronidase conjugate (lydazum) with activated derivative of poly-1,4-ethylenepiperazine N-oxide (analog of polyoxidonium) in a single dose 3000 IU by intramuscular route, 3 days before of operative removal of concrements. After removal of concrements the drug is administrated in indicated dose by the following schedule - once for 3 days, 5 injections, then once for 5 days, 15 injections, then once for 10 days, 15 injections. Proposed invention provides improvement and normalization of physicochemical and biochemical indices of urine that promotes to decreasing of relapse lithiasis.
EFFECT: improved method of prophylaxis.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING NEPHROLITHIASIS PATIENTS WITH DENSE STONES | 2018 |
|
RU2687593C1 |
| METHOD OF UROLITHIASIS RECURRENCE TREATMENT AND PREVENTION FOR MEN | 2008 |
|
RU2371182C1 |
| METHOD OF PREVENTION AND COMPLEX TREATMENT OF UROLITHIASIS AFTER DISTANT LITHOTRIPSY | 2010 |
|
RU2419427C1 |
| METHOD FOR ENDOSCOPIC TREATMENT OF PATIENTS WITH NEPHROLITHIASIS USING ALPHA-BLOCKERS | 2021 |
|
RU2779496C1 |
| METHOD FOR PREDICTION OF RISK OF RECURRENCE OF UROLITHIASIS AT STAGE OF PRIMARY CALCIUM OXALATE NEPHROLITHIASIS | 2020 |
|
RU2738012C1 |
| METHOD FOR PREVENTING LIVER INJURIES IN PERFORMING SHOCK-WAVE LITHOTRIPSY | 2006 |
|
RU2321413C1 |
| METHOD OF TREATING DISEASES COMPLICATED BY ORGAN HYPOTONIA AND ATONIA ACCOMPANYING DIABETES MELLITUS | 2012 |
|
RU2538693C2 |
| ENLARGED PLASTIC OF PELVIS OF INTRARENAL TYPE | 2018 |
|
RU2728942C2 |
| METHOD FOR PREDICTING THE RECURRENCE OF STONE FORMATION IN PATIENTS WITH UROLITHIASIS | 2021 |
|
RU2779371C1 |
| METHOD FOR DETERMINATION OF TERMS OF REPEATED SESSION OF REMOTE SHOCK-WAVE LITHOTRIPSY | 2016 |
|
RU2640948C1 |
